Antiviral Agents (chemistry) < Antiviral Agents (economics) < Antiviral Agents (history)

Facettes : AffPays.f Mesh.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
000195 (2005)	Sandro Cinti	Pandemic Influenza: Are We Ready?
000205 (2005)	L. Bonneux [Belgique]	[The threatening influenza pandemic: a national store ofoseltamivir is a waste of money].
000212 (2005)	Ran D. Balicer [Israël] ; Michael Huerta [Israël] ; Nadav Davidovitch [Israël] ; Itamar Grotto [Israël]	Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
000496 (2008)	Dorte Gyrd-Hansen [Danemark] ; Peder Andreas Halvorsen ; Ivar S Nb Kristiansen	Willingness-to-pay for a statistical life in the times of a pandemic.
000643 (2008)	M. Ruby Siddiqui [Royaume-Uni] ; W. John Edmunds [Royaume-Uni]	Cost-effectiveness of Antiviral Stockpiling and Near-Patient Testing for Potential Influenza Pandemic
000713 (2008)	Edbert B. Hsu [États-Unis] ; Michael G. Millin	A hospital-based strategy for setting priorities for antiviral prophylaxis during an influenza pandemic.
000732 (2008)	Beate Sander [Canada] ; Azhar Nizam [États-Unis] ; Louis P. Garrison [États-Unis] ; Maarten J. Postma [Pays-Bas] ; M. Elizabeth Halloran [États-Unis] ; Ira M. Longini [États-Unis]	Economic evaluation of influenza pandemic mitigation strategies in the us using a stochastic microsimulation transmission model
000868 (2010)	Anna K. Lugnér [Pays-Bas] ; Sido D. Mylius ; Jacco Wallinga	Dynamic versus static models in cost-effectiveness analyses of anti-viral drug therapy to mitigate an influenza pandemic.
000946 (2009)	Praveen Dhankhar ; Erik J. Dasbach ; Elamin H. Elbasha	Economics of stockpiling for an influenza pandemic.
000967 (2009)	Anna K. Lugnér [Pays-Bas] ; Maarten J. Postma	Investment decisions in influenza pandemic contingency planning: cost-effectiveness of stockpiling antiviral drugs.
000A40 (2010)	Arthur E. Attema [Pays-Bas] ; Anna K. Lugnér ; Talitha L. Feenstra	Investment in antiviral drugs: a real options approach.
000C27 (2009)	Carlos Del Rio [États-Unis] ; Mauricio Hernandez-Avila	Lessons from previous influenza pandemics and from the Mexican response to the current influenza pandemic.
000C81 (2008)	Elcin Yoldascan [Turquie] ; Behice Kurtaran [Turquie] ; Melik Koyuncu [Turquie] ; Esra Koyuncu [Turquie]	Modeling the Economic Impact of Pandemic Influenza: A Case Study in Turkey
000E69 (2010)	Maarten J. Postma [Pays-Bas] ; George Milne ; E Anthony S. Nelson ; Bruce Pyenson ; Marcello Basili ; Richard Coker ; John Oxford ; Louis P. Garrison	Pharmaceutical interventions for mitigating an influenza pandemic: modeling the risks and health-economic impacts.
000F78 (2011)	Olivia Prosper [États-Unis] ; Omar Saucedo ; Doria Thompson ; Griselle Torres-Garcia ; Xiaohong Wang ; Carlos Castillo-Chavez	Modeling control strategies for concurrent epidemics of seasonal and pandemic H1N1 influenza.
001292 (2012)	Jennifer C. Hunter [États-Unis] ; Daniela C. Rodríguez [États-Unis] ; Tomás J. Arag N [États-Unis]	Public health management of antiviral drugs during the 2009 H1N1 influenza pandemic: a survey of local health departments in California
001629 (2013)	George J. Milne ; Nilimesh Halder ; Joel K. Kelso	The Cost Effectiveness of Pandemic Influenza Interventions: A Pandemic Severity Based Analysis
001651 (2013)	J Kevin Yin [Australie] ; Leon Heron ; Glenn Salkeld ; Harunor Rashid ; Robert Booy	Oseltamivir use in adolescents and adults: clinical and economic considerations.
001692 (2013)	Chia-Hung Liu [Taïwan] ; Jiun-Ling Wang [Taïwan] ; Chia-Ping Su [Taïwan] ; Jen-Hsiang Chuang [Taïwan] ; Chia-Hsuin Chang [Taïwan] ; Mei-Shu Lai [Taïwan]	Oseltamivir use and outcomes during the 2009 influenza A H1N1 pandemic in Taiwan
001839 (2014)	Stacy Todd [Royaume-Uni, Viêt Nam] ; Peter J. Diggle [Royaume-Uni] ; Peter J. White [Royaume-Uni] ; Andrew Fearne [Royaume-Uni] ; Jonathan M. Read [Royaume-Uni]	The spatiotemporal association of non-prescription retail sales with cases during the 2009 influenza pandemic in Great Britain
001C36 (2017)	Mohamed A. Kamal ; Patrick F. Smith ; Nathorn Chaiyakunapruk ; David B. C. Wu ; Chayanin Pratoomsoot ; Kenneth K. C. Lee ; Huey Yi Chong ; Richard E. Nelson ; Keith Nieforth ; Georgina Dall ; Stephen Toovey ; David C. M. Kong ; Aaron Kamauu ; Carl M. Kirkpatrick ; Craig R. Rayner	Interdisciplinary pharmacometrics linking oseltamivir pharmacology, influenza epidemiology and health economics to inform antiviral use in pandemics

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Antiviral Agents (economics)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Antiviral Agents (economics)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Antiviral Agents (economics)
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021